Literature DB >> 1468989

A new indolopyrrolocarbazole antitumor substance, ED-110, a derivative of BE-13793C.

S Tanaka1, M Ohkubo, K Kojiri, H Suda, A Yamada, D Uemura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1468989     DOI： 10.7164/antibiotics.45.1797

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  3 in total

1.  Cytotoxic Indolocarbazoles from Actinomadura melliaura ATCC 39691.

Authors:  Khaled A Shaaban; Sherif I Elshahawi; Xiachang Wang; Jamie Horn; Madan K Kharel; Markos Leggas; Jon S Thorson
Journal:  J Nat Prod       Date:  2015-06-19       Impact factor: 4.050

2.  A Co-Culturing Approach Enables Discovery and Biosynthesis of a Bioactive Indole Alkaloid Metabolite.

Authors:  Fleurdeliz Maglangit; Qing Fang; Kwaku Kyeremeh; Jeremy M Sternberg; Rainer Ebel; Hai Deng
Journal:  Molecules       Date:  2020-01-08       Impact factor: 4.411

3.  ED-110, a novel indolocarbazole, prevents the growth of experimental tumors in mice.

Authors:  H Arakawa; T Iguchi; T Yoshinari; K Kojiri; H Suda; A Okura
Journal:  Jpn J Cancer Res       Date:  1993-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.